Showing results (1501-1510 of 5,275) with videos related to

Sort By:
Pageof 528
Oncology|March 20, 2004
Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinomaMasafumi Ikeda, Seishi Maeda, Junji Shibata, et al.
Oncology|March 20, 2004
Pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 in normal mice after systemic exposure to effective and safe antitumor dosesJosephia R Muindi, Ruth A Modzelewski, Yibing Peng, et al.
Oncology|November 28, 2021
The Impact of Routine Molecular Screening for SARS-CoV-2 in Patients Receiving Anticancer Therapy: An Interim Analysis of the Observational COICA StudyGiuseppe Di Lorenzo, Mario Iervolino, Ferdinando Primiano, et al.
Oncology|November 29, 2021
Post-Progression Survival Highly Influences Overall Survival in Driver Gene Mutation/Translocation Negative or Unknown Type of Non-Small Cell Lung CancerHisao Imai, Ryoichi Onozato, Kyoichi Kaira, et al.
Oncology|September 13, 2022
Biological Difference between L858R and Exon 19 Deletion Contributes to Recurrence-Free Survival of Resected Non-Small Cell Lung CancerKatsuhiro Masago, Hiroaki Kuroda, Shiro Fujita, et al.
Oncology|September 14, 2022
Revisiting the Evidence for Routine Transcervical Thymectomy for the Prevention of Thymic Carcinoid Tumours in MEN-1 PatientsMechteld Christine De Jong, Rajeev Parameswaran
Oncology|December 16, 2021
Evaluation of Clinical Significance of Lymphovascular Space Invasion in Stage IA Endometrial CancerKaoru Okugawa, Hideaki Yahata, Kazuhisa Hachisuga, et al.
Oncology|November 24, 2021
Prognoses in Pathologically Confirmed T1 Lower Rectal Cancer Patients with or without Preoperative Therapy: An Analysis Using the Surveillance, Epidemiology, and End Results DatabaseTetsuro Taira, Hiroaki Nozawa, Kazushige Kawai, et al.
Oncology|December 30, 2021
Beyond Front-Line Therapy for Unresectable Gastroesophageal Adenocarcinoma: Are There Differences in Subsequent Therapy Sequencing?Jane E Rogers, Xuemei Wang, Allison Trail, et al.
Oncology|March 7, 2021
Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor TherapyKei Amioka, Tomokazu Kawaoka, Yutaro Ogawa, et al.
Pageof 528